Table 5.
Genotype distribution and allele frequencies of the VEGF -2578 C/A polymorphism in control and case group
Genotype | Fetus | Mother | Father | |||
---|---|---|---|---|---|---|
VEGF -2578 C/A |
Controls N = 100 (%) |
Cases N = 100 (%) |
Controls N = 100 (%) |
Cases N = 100 (%) |
Controls N = 100 (%) |
Cases N = 100 (%) |
CC | 38 (38%) | 25 (25%) | 32 (32%) | 35 (35%) | 76 (76%) | 78 (78%) |
CA | 48 (48%) | 56 (56%) | 48 (48%) | 50 (50%) | 22 (22%) | 15 (15%) |
AA | 14 (14%) | 19 (19%) | 20 (20%) | 15 (15%) | 2 (2%) | 7 (7%) |
C | 124 (0.62) | 106 (0.53) | 112 (0.56) | 120 (0.60) | 170 (0.85) | 174 (0.87) |
A | 76 (0.38) | 94 (0.47) | 88 (0.44) | 80 (0.40) | 30 (0.15) | 26 (0.13) |
HWE p value |
0.03 0.86 |
1.54 0.21 |
0.07 0.79 |
0.17 0.68 |
0.08 0.77 |
15.61 < 0.00001** |
OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | |
CA Vs CC | 1.77 (0.94–3.34) | 0.06 | 0.95 (0.51–1.77) | 0.87 | 0.66 (0.32–1.37) | 0.26 |
AA Vs CC | 2.06 (0.87–4.85) | 0.09 | 0.68 (0.30–1.56) | 0.36 | 3.41 (0.68–16.94) | 0.11 |
CA + AA Vs CC | 1.83 (1.00–3.37) | 0.04* | 0.87 (0.48–1.57) | 0.65 | 0.89 (0.46–1.72) | 0.7 |
AA Vs CC + CA | 0.69 (0.32–1.47) | 0.34 | 1.41 (0.67–2.95) | 0.35 | 0.27 (0.05–1.33) | 0.08 |
CA Vs CC + AA | 1.39 (0.77–2.51) | 0.1 | 1.08 (0.60–1.95) | 0.9 | 0.62 (0.28–1.35) | 0.2 |
A Vs C | 1.44 (0.97–2.15) | 0.06 | 0.84 (0.57–1.26) | 0.41 | 1.13 (0.64–2.00) | 0.66 |
p value < 0.05* is statistically significant, p value < 0.001**